A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy

Brain

Volumn 135, Issue 3, 2012, Pages 900-911

  Skoog, Bengt ^a   Runmarker, Björn ^a   Winblad, Stefan ^a   Ekholm, Sven ^b   Andersen, Oluf ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

cognitive symptoms; disability; MRI; multiple sclerosis; prognosis

Indexed keywords

ARTICLE; COGNITION; CORPUS CALLOSUM; DISEASE COURSE; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; RELAPSE; REMISSION; SURVIVAL RATE; VERBAL MEMORY;

EID: 84857528669     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr336     Document Type: Article

References (58)

1. Ahlgren C, Oden A, Lycke J. High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler 2011;17:901-8.
2. Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, Ricchiuti L, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 2006;253:1054-9.
3. Andersen O. Restricted dissemination of clinically defined attacks in an MS incidence material. Acta Neurol Scand Suppl 1980;77:1-70.
4. Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T. Cancer risk among patients with multiple sclerosis and their parents. Neurology 2009;72:1170-7.
5. Baig S, Olsson T, Yu-Ping J, Hojeberg B, Cruz M, Link H. Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid. Scand J Immunol 1991;33:73-9.
6. Beck A, Steer R. Beck Depression Inventory. Manual - Swedish version: Psykologiförlaget; 1996.
7. Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, et al. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis. Mult Scler 2009;15:789-94.
8. Broman T, Andersen O, Bergmann L. Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenburg. Acta Neurol Scand 1981;63:6-33.
9. Charcot JM. Leçons sur les maladies du système nerveux faites à la Salpêtrière. 3rd edn. Paris: A. Delahaye; 1877.
10. Chard DT, Dalton CM, Swanton J, Fisniku LK, Miszkiel KA, Thompson AJ, et al. MRI only conversion to multiple sclerosis following a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 2011;82:176-9.
11. Chiaravalloti ND, De Luca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139-51.
12. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-8.
13. Costelloe L, Thompson A, Walsh C, Tubridy N, Hutchinson M. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J Neurol Neurosurg Psychiatry 2008;79:1245-8.
14. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-91.
15. Eriksson M, Andersen O, Runmarker B. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 2003;9:260-74.
16. Gauthier SA, Berger AM, Liptak Z, Duan Y, Egorova S, Buckle GJ, et al. Rate of brain atrophy in benign vs early multiple sclerosis. Arch Neurol 2009;66:234-7.
17. Glad SB, Aarseth JH, Nyland H, Riise T, Myhr KM. Benign multiple sclerosis: a need for a consensus. Acta Neurol Scand Suppl 2010;44-50.
18. Hawkins SA, McDonnell GV. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999;67:148-52.
19. Hellstrom P, Edsbagge M, Archer T, Tisell M, Tullberg M, Wikkelso C. The neuropsychology of patients with clinically diagnosed idiopathic normal pressure hydrocephalus. Neurosurgery 2007;61:1219-26. discussion 27-8.
20. Hirst C, Ingram G, Swingler R, Compston DA, Pickersgill T, Robertson NP. Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis. J Neurol Neurosurg Psychiatry 2008;79:1137-43.
21. Johns M, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep 1997;20:844-9.
22. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
23. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999;122(Pt 1):17-26.
24. Koch-Henriksen N, Bronnum-Hansen H, Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry 1998;65:56-9.
25. Kurland LT. The evolution of multiple sclerosis epidemiology. Ann Neurol 1994;36(Suppl):S2-5.
26. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
27. Lezak MD. Neuropsychological assessment. 3rd edn. New York: Oxford University Press; 1995.
28. Liu C, Blumhardt LD. Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts. J Neurol Neurosurg Psychiatry 2000;68:450-7.
29. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 1996;46:907-11.
30. Mastorodemos V, Nikolakaki H, Tzagournissakis M, Kotzamani D, Panou T, Spanaki C, et al. Benign multiple sclerosis in Crete. Mult Scler 2010;16:701-6.
31. McAlpine D, Compston N. Some aspects of the natural history of disseminated sclerosis. Q J Med 1952;21:135-67.
32. Midgard R, Albrektsen G, Riise T, Kvale G, Nyland H. Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in More and Romsdal, Norway. J Neurol Neurosurg Psychiatry 1995;58:417-21.
33. Minderhoud JM, van der Hoeven JH, Prange AJ. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand 1988;78:10-5.
34. Nordlund A, Rolstad S, Klang O, Lind K, Pedersen M, Blennow K, et al. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI. J Int Neuropsychol Soc 2008;14:582-90.
35. Oppenheim. Zur Pathologie der disseminierten Sclerose. Klinische Wochenschrift 1887;24:904-7.
36. Pittock SJ, McClelland RL, Mayr WT, Jorgensen NW, Weinshenker BG, Noseworthy J, et al. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 2004;56:303-6.
37. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
38. Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, et al. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 2009;73:498-503.
39. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
40. Ramsaransing GS, De Keyser J. Benign course in multiple sclerosis: a review. Acta Neurol Scand 2006;113:359-69.
41. Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995;45:244-50.
42. Rovaris M, Riccitelli G, Judica E, Possa F, Caputo D, Ghezzi A, et al. Cognitive impairment and structural brain damage in benign multiple sclerosis. Neurology 2008;71:1521-6.
43. Rovaris M, Barkhof F, Calabrese M, De Stefano N, Fazekas F, Miller DH, et al. MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype. Neurology 2009;72:1693-701.
44. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993;116(Pt 1):117-34.
45. Runmarker B, Andersson C, Oden A, Andersen O. Prediction of outcome in multiple sclerosis based on multivariate models. J Neurol 1994;241:597-604.
46. Sackett D, Haynes B, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston: Little, Brown co; 1991.
47. Sayao AL, Devonshire V, Tremlett H. Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Neurology 2007;68:496-500.
48. Sayao AL, Bueno AM, Devonshire V, Tremle TT. The Ubc Ms Clinic Neurologists H. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis. Mult Scler 2011;11:1375-1383.
49. Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, et al. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain 2010;133:1914-29.
50. Simon JH, Li D, Traboulsee A, Coyle PK, Arnold DL, Barkhof F, et al. Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol 2006;27:455-61.
51. Svenningsson A, Runmarker B, Lycke J, Andersen O. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand 1990;82:161-8.
52. Thompson AJ. Benign multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;67:138.
53. Trojano M, Pellegrini F, Fuiano A, Paolicelli D, Zipoli V, Zimatore G, et al. Reply. Ann Neurol 2008;63:126-7.
54. Uchino A, Takase Y, Nomiyama K, Egashira R, Kudo S. Acquired lesions of the corpus callosum: MR imaging. Eur Radiol 2006;16:905-14.
55. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 1999;66:184-8.
56. Vukusic S, Confavreux C. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. J Neurol Sci 2003;206:135-7.
57. Wechsler D, Bartfai A, Nyman H, Stegmann B. Wechsler Adult Intelligence Scale-revised. Swedish manual. Stockholm: Psykologiförlaget; 1992.
58. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 1989;112(Pt 1):133-46.